Comprehensive Cancer Panel Sequencing Defines Genetic Diversity and Changes in the Mutational Characteristics of Pancreatic Cancer Patients Receiving Neoadjuvant Treatment.

Kyong-Ah Yoon Sang-Myung Woo Yun-Hee Kim Sun-Young Kong Min Kyoung Lee Sung-Sik Han Tae Hyun Kim Woo Jin Lee Sang-Jae Park

Published in: Gut and liver (2020)

These results indicate that tumor tissue from PDA patients is genetically diverse and suggest that ARID1A mutations may be a potential prognostic marker for PDA.

Keyphrases

genetic diversity
end stage renal disease
newly diagnosed
ejection fraction
prognostic factors
rectal cancer
lymph node
single cell
locally advanced
radiation therapy
patient reported outcomes
combination therapy
human health